.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Harvard Business School
QuintilesIMS
Chubb
Express Scripts
Federal Trade Commission
Chinese Patent Office
Fish and Richardson
Mallinckrodt
Cantor Fitzgerald

Generated: June 24, 2017

DrugPatentWatch Database Preview

SLO-BID Drug Profile

« Back to Dashboard

Which patents cover Slo-bid, and what generic Slo-bid alternatives are available?

Slo-bid is a drug marketed by Sanofi Aventis Us and is included in six NDAs.

The generic ingredient in SLO-BID is theophylline. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the theophylline profile page.

Summary for Tradename: SLO-BID

Patents:0
Applicants:1
NDAs:6
Bulk Api Vendors: see list84
Clinical Trials: see list2,419
Patent Applications: see list9,777
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SLO-BID at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
SLO-BID
theophylline
CAPSULE, EXTENDED RELEASE;ORAL089539-001May 10, 1989DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
SLO-BID
theophylline
CAPSULE, EXTENDED RELEASE;ORAL087892-001Jan 31, 1985DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
SLO-BID
theophylline
CAPSULE, EXTENDED RELEASE;ORAL089540-001May 10, 1989DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
SLO-BID
theophylline
CAPSULE, EXTENDED RELEASE;ORAL088269-001Jan 31, 1985DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
SLO-BID
theophylline
CAPSULE, EXTENDED RELEASE;ORAL087894-001Jan 31, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Medtronic
Novartis
Boehringer Ingelheim
Chubb
Federal Trade Commission
Fuji
Julphar
Teva
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot